Main Subject - Internet and Businesses Online

Using joint venture partners (JVs) to build your list can be a strong option, espe

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

cially if you have at least 500 subscribers on your list. This has been my second

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

strongest method of generating leads online, although as my list has grown, I part

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

cipate in these more frequently.

The basic list building idea with JVs is that yo

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

u offer to mail your list an offer for another list builder, and he or she mails o

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

e for you. Generally you are not trying to sell anything to the list, you are sim

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

ply gathering subscribers to your own list. These subscribers tend to be very pro

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

ductive – they are the cream of the crop, so to speak. Basically the subscribers w

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

o respond to the JV email are the biggest responders, because they are already on

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

an email list, they obviously read their emails, and they have responded to your o

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

fer. They tend to be very responsive to future emailings from you.

The one thing

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

to be aware of is that in performing the email swap, you are also mailing an offe

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

r for the other marketer, so he in turn can get access to some of your best subscr

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

bers. Because you are allowing your subscribers’ an easy way to get on someone el

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

se’s list, they are going to be getting more emails. This means that the value of

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

your own email to them now goes down.

All in all, I think that the added leads yo

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

u get by participating in the swaps are worth the ones you lose – although I have

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

been cutting back on the number of swaps I do because I have found that my respons

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

rate on my entire list seems to go down after I do a few swaps. This is very dif

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

ficult to quantify without extensive testing, and I do not have hard numbers on it

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/71400/mainsubjects-List-Building-With-JV-Partners-I.html">List Building With JV Partners I</a>

BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/71400/mainsubjects-List-Building-With-JV-Partners-I.html]List Building With JV Partners I[/url]

Employee conflicts in the workplace can be detrimental to performance and productivity. Using a simple process for resolving conflicts can create a better work environment for everyone.

Dr. Gary S. Goodman, sales and service coach, best-selling author, says we should appreciate inbound inquiries more than we do, and drop everything to give them first class attention. This popular speaker and radio and TV expert guest points out, that by comparison, cold calling and other lead generation efforts are much more costly and much less effective.

Going into your workday and waiting for things to happen, and then reacting to them is not a very productive way of doing things. You may as well be going into your workday blind.

Tags

Links

Main Subject - List Building With JV Partners I

Related Articles: